Metro Healthcare Indonesia Tbk PT
IDX:CARE
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
75
193
|
Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one CARE stock under the Base Case scenario is 13.11 IDR. Compared to the current market price of 156 IDR, Metro Healthcare Indonesia Tbk PT is Overvalued by 92%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Metro Healthcare Indonesia Tbk PT
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for CARE cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Metro Healthcare Indonesia Tbk PT
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Metro Healthcare Indonesia Tbk PT
Balance Sheet Decomposition
Metro Healthcare Indonesia Tbk PT
Current Assets | 720.4B |
Cash & Short-Term Investments | 673.9B |
Receivables | 35.8B |
Other Current Assets | 10.7B |
Non-Current Assets | 3.3T |
PP&E | 3.3T |
Intangibles | 7B |
Other Non-Current Assets | 4.4B |
Current Liabilities | 880B |
Accounts Payable | 17.6B |
Accrued Liabilities | 25B |
Short-Term Debt | 794.4B |
Other Current Liabilities | 43.1B |
Non-Current Liabilities | 124.5B |
Long-Term Debt | 115.7B |
Other Non-Current Liabilities | 8.8B |
Earnings Waterfall
Metro Healthcare Indonesia Tbk PT
Revenue
|
312.9B
IDR
|
Cost of Revenue
|
-219.5B
IDR
|
Gross Profit
|
93.4B
IDR
|
Operating Expenses
|
-133.5B
IDR
|
Operating Income
|
-40.1B
IDR
|
Other Expenses
|
-76.1B
IDR
|
Net Income
|
-116.2B
IDR
|
Free Cash Flow Analysis
Metro Healthcare Indonesia Tbk PT
IDR | |
Free Cash Flow | IDR |
CARE Profitability Score
Profitability Due Diligence
Metro Healthcare Indonesia Tbk PT's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
Score
Metro Healthcare Indonesia Tbk PT's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
CARE Solvency Score
Solvency Due Diligence
Metro Healthcare Indonesia Tbk PT's solvency score is 46/100. The higher the solvency score, the more solvent the company is.
Score
Metro Healthcare Indonesia Tbk PT's solvency score is 46/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CARE Price Targets Summary
Metro Healthcare Indonesia Tbk PT
Dividends
Current shareholder yield for CARE is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
PT Metro Healthcare Indonesia Tbk engages in the provision of integrated healthcare services. The company is headquartered in Tangerang, Banten and currently employs 713 full-time employees. The company went IPO on 2020-03-13. The firm operates its business in an integrated health service with hospital under Metro Hospital Group. The company is focused on developing technology-based health services and training centers to produce professionals in health services. The firm offers healthcare service with a range of services and facilities including polyclinic, ICU room, class III inpatient room and Super VIP room ready to cater various type of patients. The firm operates RSIA Bunda Sejahtera, RSU Bina Sehat Mandiri, RSU Metro Hospitals Cikarang, RSU Metro Hospitals Cikupa, RSU Kartini, RSIA Mitra Husada, and RSIA Santo Yusuf. Its subsidiaries include PT Metro Global Medika, PT Metro Healthcare Technologies, PT Metro Medika Abadi, PT Mitra Adika Buana, PT Metro Hospitals Indonesia, PT Metro Mitra Sarana, PT Eka Tunggal Jaya, PT Paramudya Dasa Sakti, PT Indah Nusa Indonesia, PT Sejahtera Berkah Berdikari, and PT Berkarya Sejahtera Gemilang.
Contact
IPO
Employees
Officers
The intrinsic value of one CARE stock under the Base Case scenario is 13.11 IDR.
Compared to the current market price of 156 IDR, Metro Healthcare Indonesia Tbk PT is Overvalued by 92%.